MPM Oncology Impact Management LP 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
MO MPM Oncology Impact Management LP | Institutional Filer | ▲ 48.17% | $1.29B | 41 |
Current Portfolio Holdings
Showing all 41 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | DBVT | DBV Technologies S.A. | Healthcare | 5.2M | $108.9M | 8.41% |
| 2 | CGEM | Cullinan Therapeutics, Inc. | Healthcare | 7.6M | $108.7M | 8.39% |
| 3 | AKTS | Aktis Oncology, Inc. | — | 4.8M | $86.5M | 6.68% |
| 4 | LQDA | Liquidia Corporation | Healthcare | 1.4M | $53.0M | 4.10% |
| 5 | ALMS | Alumis Inc. Common Stock | Healthcare | 2.4M | $52.6M | 4.06% |
| 6 | EWTX | Edgewise Therapeutics, Inc. | Healthcare | 1.7M | $52.3M | 4.04% |
| 7 | RVMD | Revolution Medicines, Inc. | Healthcare | 507K | $49.3M | 3.81% |
| 8 | AGIO | Agios Pharmaceuticals, Inc. | Healthcare | 1.3M | $44.2M | 3.41% |
| 9 | CORT | Corcept Therapeutics Incorporated | Healthcare | 986K | $39.7M | 3.07% |
| 10 | TRVI | Trevi Therapeutics, Inc. | Healthcare | 3.3M | $39.4M | 3.04% |
| 11 | DNTH | Dianthus Therapeutics, Inc. | Healthcare | 424K | $35.6M | 2.75% |
| 12 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 589K | $34.2M | 2.64% |
| 13 | MLTX | MoonLake Immunotherapeutics | Healthcare | 1.8M | $33.8M | 2.61% |
| 14 | TVTX | Travere Therapeutics, Inc. | Healthcare | 1.1M | $33.7M | 2.60% |
| 15 | EVMN | Evommune, Inc. | — | 1.5M | $33.5M | 2.58% |
Showing 1 to 15 of 41 holdings